Stocks EVCM Financial statements
Financial statementsEverCommerce Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data EverCommerce Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 242 | 338 | 490 | 621 | 535 | 562 | 589 |
| Cost of revenue | 73.1 | 115 | 162 | 217 | 127 | 125 | 132 |
| Gross profit | 169 | 223 | 328 | 403 | 407 | 437 | 457 |
| Research and development | 26.1 | 30.4 | 49.5 | 71.6 | 72.1 | 76.2 | 79 |
| Selling and marketing | 46.3 | 50.2 | 93.8 | 119 | 114 | 114 | 120 |
| General and administrative | 98 | 87.1 | 110 | 132 | 123 | 129 | 132 |
| Operating income | -54.3 | -22 | -27.2 | -30.6 | -2.92 | 26.2 | 59.3 |
| Interest expense | 28.8 | 43.7 | 41.7 | 34.7 | |||
| Interest income | 0.26 | 1.02 | 3.11 | 3.43 | |||
| Other non-operating income | -40 | -41.5 | -36.1 | -33.9 | -46.4 | -35.6 | -38.1 |
| Pre-tax income | -110 | -63.6 | -92 | -64.5 | -49.3 | -9.36 | 21.2 |
| Income tax | -16 | -3.63 | -10.1 | -4.68 | 1.38 | 5.84 | 2.96 |
| Income from continuing operations | -50.7 | -15.2 | 18.2 | ||||
| Net income | -93.7 | -60 | -82 | -59.8 | -45.6 | -41.1 | 17.6 |
| EBITDA | -1.31 | 54.8 | 74.2 | 80.2 | 101 | 115 | 128 |
| EPS, basic | -14.13 | -3.06 | -0.82 | -0.31 | -0.24 | -0.22 | 0.10 |
| EPS, diluted | -14.13 | -3.06 | -0.82 | -0.31 | -0.24 | -0.22 | 0.10 |
| Shares, basic (weighted) | 27.1 | 41.7 | 118 | 195 | 189 | 185 | 181 |
| Shares, diluted (weighted) | 27.1 | 41.7 | 118 | 195 | 189 | 185 | 184 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 57.3 | 96 | 94 | 92.6 | 92.6 | 136 | 130 |
| Receivables | 25 | 40.5 | 48 | 45.4 | 31.1 | 37 | |
| Other current assets | 10.7 | 22.5 | 23.8 | 22.4 | 27.2 | 34.4 | |
| Total current assets | 144 | 172 | 181 | 180 | 218 | 213 | |
| Property, plant and equipment | 14.7 | 13.5 | 11.9 | 9.73 | 6.13 | 5.74 | |
| Lease right-of-use assets | 21.8 | 15.9 | 10.5 | 8.28 | |||
| Goodwill | 427 | 668 | 921 | 914 | 876 | 863 | 894 |
| Intangible assets | 471 | 509 | 406 | 316 | 211 | 164 | |
| Other non-current assets | 14.1 | 24.3 | 46.9 | 42.7 | 36.1 | 36.3 | |
| Total assets | 1,328 | 1,663 | 1,592 | 1,518 | 1,421 | 1,372 | |
| Accounts payable | 11.1 | 10.3 | 8.37 | 8.64 | 6.6 | 5.13 | |
| Accrued liabilities | 46.4 | 49.3 | 57 | 66.3 | 50.8 | 55.8 | |
| Deferred revenue | 13.6 | 23 | 22.9 | 24.1 | 22.1 | 21.7 | |
| Short-term debt | 7.29 | 10.9 | 5.5 | 5.5 | 5.5 | 5.5 | |
| Total current liabilities | 86.7 | 103 | 105 | 117 | 111 | 101 | |
| Long-term debt | 691 | 535 | 531 | 527 | 522 | 518 | |
| Lease liabilities | 22.5 | 19.4 | 13.2 | 9.96 | |||
| Other non-current liabilities | 17.6 | 39.1 | 49 | 48 | 36.3 | 36.4 | |
| Total liabilities | 808 | 678 | 685 | 692 | 670 | 655 | |
| Total debt | 698 | 546 | 536 | 532 | 528 | 523 | |
| Paid-in capital | 40.6 | 1,501 | 1,490 | 1,454 | 1,426 | 1,373 | |
| Retained earnings | -431 | -513 | -573 | -620 | -661 | -643 | |
| Other comprehensive income | 1.55 | -1.77 | -10.2 | -8.02 | -14.3 | -12.7 | |
| Shareholders' equity | -275 | -389 | 986 | 907 | 826 | 751 | 717 |
| Total equity | -275 | -389 | 986 | 907 | 826 | 751 | 717 |
| Total liabilities and equity | 1,328 | 1,663 | 1,592 | 1,518 | 1,421 | 1,372 | |
| Shares outstanding | 43.1 | 195 | 191 | 187 | 184 | 178 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | -93.7 | -60 | -82 | -59.8 | -45.6 | -41.1 | 17.6 |
| Depreciation and amortization | 52.9 | 76.8 | 101 | 111 | 104 | 88.8 | 68.4 |
| Stock-based compensation | 30.1 | 10.7 | 22.1 | 26.8 | 25.6 | 26.5 | 28.4 |
| Deferred income tax | -16 | -4.31 | -12 | -7.48 | -1.76 | 2.91 | -0.53 |
| Change in receivables | -3.01 | -0.52 | -13.3 | -13.2 | -5.01 | -0.32 | -14 |
| Change in payables | 1.13 | 2.89 | -3.96 | -1.87 | 0.18 | -0.25 | -1.71 |
| Cash from operations | -0.61 | 57.5 | 37.5 | 64.8 | 105 | 113 | 111 |
| Capital expenditures | -7.67 | -4.53 | -3.1 | -2.57 | -3.04 | -1.46 | -2.23 |
| Acquisitions | -310 | -403 | -365 | 0 | -14.9 | 0 | -35.8 |
| Cash from investing | -324 | -418 | -380 | -18.1 | -38 | -12.3 | -30.6 |
| Debt issued | 688 | 315 | 851 | 0 | 0 | ||
| Debt repaid | -475 | -55.9 | -1,028 | -9.5 | -5.5 | -5.5 | -5.5 |
| Stock issued | 0 | 0 | 416 | 0 | 0 | 4.11 | 7.71 |
| Share buybacks | -23.5 | 0 | 0 | -43 | -67.3 | -57.7 | -85.1 |
| Cash from financing | 310 | 402 | 341 | -47.3 | -66.6 | -59.6 | -87.6 |
| Exchange rate effect | -0.3 | -0.09 | 0.22 | -1.15 | 0.4 | -1.65 | 0.62 |
| Net change in cash | -15 | 41 | -0.78 | -1.74 | 0.36 | 39.6 | -6.05 |
| Free cash flow | -8.28 | 53 | 34.4 | 62.2 | 102 | 112 | 109 |
| Interest paid | 34 | 35.2 | 30.8 | 30.1 | 46 | 45.5 | 35.7 |
| Income taxes paid | 0.34 | 0.74 | 1.5 | 2.51 | 3.11 | 4.55 | 3.09 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 77.8% | Gross profit / revenue. |
| Operating margin | 9.9% | Operating income / revenue. |
| EBITDA margin | 20.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 5.3% | Pre-tax income / revenue. |
| Net margin | 5.7% | Net income / revenue. |
| FCF margin | 17.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 17.9% | Cash from operations / revenue. |
| Effective tax rate | 10.4% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 4.8% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 2.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | 4.8% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 13.7% | Research and development expense / revenue. |
| Stock-based pay / revenue | 4.1% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.5% | Capital expenditures / revenue. |
| D&A / revenue | 10.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 4.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -1.7% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 11.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 4.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 4.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 15.5% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 126.1% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | 11.0% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 16.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 18.4% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -1.5% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 19.8% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 14.1% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -2.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 20.6% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 15.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -4.5% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -7.5% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -3.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -4.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 0.7% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -0.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -1.9% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 34.6% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.14x | Current assets / current liabilities. |
| Quick ratio | 1.68x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.31x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.73x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 38.2% | Total debt / total assets. |
| Liabilities / assets | 47.6% | Total liabilities / total assets. |
| Net debt | $387.4M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 3.14x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 1.78x | Operating income / interest expense. |
| Working capital | $116.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 65.4% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$177.3M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.44x | Revenue / average total assets. |
| Fixed asset turnover | 99.1x | Revenue / average property, plant and equipment. |
| Receivables turnover | 15.9x | Revenue / average receivables. |
| Days sales outstanding | 23 days | 365 x average receivables / revenue. |
| Days payables | 30 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 306.1% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 2.5% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.19 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $3.35 | Revenue / diluted weighted shares. |
| FCF per share | $0.58 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.60 | Cash from operations / diluted weighted shares. |
| Book value per share | $4.05 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$1.00 | Tangible book value / shares outstanding. |
| Cash per share | $0.76 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 78.8% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.43B | Share price x shares outstanding. |
| Enterprise value | $1.81B | Market cap + total debt - cash - short-term investments. |
| P/E | 41.9x | Market cap / net income. Only when net income is positive. |
| P/S | 2.39x | Market cap / revenue. |
| P/B | 2.00x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 13.7x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 13.3x | Market cap / cash from operations, when positive. |
| EV/Sales | 3.03x | Enterprise value / revenue. |
| EV/EBIT | 30.6x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 14.7x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 17.4x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 7.3% | Free cash flow / market cap. |
| Earnings yield | 2.4% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 5.8% | (Dividends paid + share buybacks) / market cap. |
What was EverCommerce Inc.'s revenue in fiscal 2025?
EverCommerce Inc. reported revenue of $588.9M for fiscal 2025, 4.8% higher than the year before.
Was EverCommerce Inc. profitable in fiscal 2025?
Yes. Net income was $17.6M, a net margin of 3%.
How much free cash flow did EverCommerce Inc. generate in fiscal 2025?
Cash from operations of $111.5M minus capital expenditures of $2.2M left free cash flow of $109.2M.